Drama is the deepest acquisition lane in the indie market, and the 2026 numbers show that depth more clearly than the trade-press narrative suggests. Netflix logged 1,277 drama-tagged buyer signals year-to-date through May 26, 2026, roughly five times the volume of the next-most-active buyer. Paramount+ followed at 297, HBO at 168, Hulu at 167, Lionsgate at 153. April 2026 alone saw 1,330 drama signals against 768 in March, a near-doubling that tracks the spring acquisition cycle running from Berlin through SXSW into pre-Cannes positioning.
The headline pattern in drama in 2026 is platform concentration. The top five drama buyers by signal volume are all streaming or platform-hybrid entities. The traditional theatrical distributors that anchored prestige drama five years ago appear lower in the volume rankings, not because they stopped acquiring but because the platforms are buying more, more publicly, across a wider mandate. Active drama buyers expanded from 181 in January to 247 in May, so the buyer pool is widening even as the top of the chart consolidates.
The full breakdown is below.
The 10 most active drama buyers in 2026
These are the in-scope buyers (distributors, streamers, sales agents, production companies) tagged with drama in our canonical data, ranked by total trade-press signal volume from January 1 through May 26, 2026. Signal counts are not deal counts; one buyer can generate multiple signals from one article when they appear in multiple capacities.
| Rank | Buyer | Signals (YTD) | Last 90d | Last 30d | |---|---|---:|---:|---:| | 1 | Netflix | 1,277 | 973 | 274 | | 2 | Paramount+ | 297 | 246 | 49 | | 3 | HBO | 168 | 116 | 37 | | 4 | Hulu | 167 | 123 | 18 | | 5 | Lionsgate | 153 | 109 | 42 | | 6 | Apple TV+ | 104 | 56 | 7 | | 7 | Peacock | 101 | 66 | 22 | | 8 | NBC | 95 | 72 | 32 | | 9 | Universal Pictures | 73 | 54 | 16 | | 10 | MUBI | 63 | 52 | 37 |
A note on the Netflix lead: the 5x gap between Netflix and Paramount+ is genuine but partially shaped by Netflix's continuous global trade-press coverage. Netflix appears in trade reporting nearly daily for one project or another, while specialty distributors generate burst coverage tied to specific acquisitions. The number is correct as a measure of trade-press presence, but readers should not interpret it as "Netflix acquires five times as many drama scripts as Paramount+." It measures coverage, not deals.
The MUBI entry at tenth is the most interesting line on the table for indie writers. MUBI logged 37 drama signals in the last 30 days alone, the third-highest 30-day rate on this list behind Netflix and Paramount+. The company is moving aggressively into theatrical drama acquisition while continuing its streaming-platform mandate. For writers with festival-bound prestige drama, MUBI is currently a hotter active target than its overall rank suggests.
Beyond the top 10: the specialty drama buyers
The next tier of drama buyers below the top 10 is where most of the spec acquisitions for unrepresented or early-career writers actually happen. The most active specialty and indie names in our 2026 drama data:
| Buyer | Type | Drama signals 2026 | Last 30d | |---|---|---:|---:| | Sony Pictures Classics | Specialty distributor | 43 | 20 | | Fifth Season | Production / sales | 20 | 3 | | Charades | Sales agent | 20 | 5 | | CJ ENM | Korean producer | 19 | 6 | | Greenwich Entertainment | Boutique distributor | 18 | 10 | | Janus Films | Specialty / repertory | 18 | 1 | | Vertical | Boutique distributor | 17 | 6 |
The international names here are worth flagging. Charades (French sales agent) and CJ ENM (Korean producer of Parasite and a wide international slate) both show meaningful 2026 drama signal volume. The international co-production market for drama is more active than the U.S.-centric trade-press narrative typically captures.
The other line worth pulling out: Greenwich Entertainment's 10 signals in the last 30 days. Greenwich runs a small annual theatrical slate of acquired drama. Ten signals in a single 30-day window for a buyer of that scale represents a meaningful acquisition burst, likely tied to spring festival activity.
Monthly volume in 2026
| Month (2026) | Drama signals | Active drama buyers | |---|---:|---:| | January | 592 | 181 | | February | 694 | 169 | | March | 768 | 151 | | April | 1,330 | 211 | | May (through May 26) | 1,023 | 247 |
Three things in this table. April's signal volume jumped 73% over March, driven by the same spring festival cycle that drove the parallel horror surge (SXSW, Overlook, pre-Cannes positioning). May's signal count is partial (data through May 26, four-to-five days short of the full month), and the per-day rate in May is running ahead of April's pace. The active-buyer count keeps expanding, rising from 181 in January to 247 in May, which means the pool is widening as the volume scales.
What this means for drama writers
The data divides the practical takeaway by tier of project.
For platform-shaped drama (limited series, prestige episodic, streaming-original feature): the top five names on the list represent your realistic targets, but the path runs almost exclusively through representation. None of these buyers reads unsolicited material directly. The realistic pathway is to land at an agency that packages drama, attach to a producer with platform overall deals, or develop with a production company that has output deals at Netflix, Paramount+, HBO, Hulu, or Lionsgate.
For specialty theatrical drama: the second-tier list matters more than the top ten. Sony Pictures Classics, MUBI, and Greenwich Entertainment are buying actively, and the pathway is festival-driven. A specialty drama project that premieres at Sundance, Berlin, TIFF, or Cannes lands in front of these buyers with much less friction than a cold spec submission ever could.
For international-leaning drama: Charades, CJ ENM, and similar international sales agents and producers are an underused pathway in U.S. writer thinking. If your drama has international cast attached, international financing potential, or a co-production hook, the sales-agent pathway moves faster and reaches more international territory buyers than the U.S. distribution route.
For drama specs broadly: the trend in 2026 is that buyers reward hybrid-genre drama (drama-thriller, prestige horror with drama bones, character-driven crime) more readily than pure drama. The list of most-active buyers acquires across genres, and what gets attention in those mandates is usually drama that crosses into something else.
The drama buyers page lists every drama-tagged buyer with a published profile, and the individual profiles for Netflix, Hulu, Lionsgate, MUBI, and Sony Pictures Classics carry the live activity counts and mandate analysis underneath this aggregate report.
Methodology and limits
All counts in this report were pulled from ScriptMatch's buyer-intelligence database on May 26, 2026. The drama filter pulls every buyer whose canonical genre data includes a drama tag. One known limit: a buyer whose canonical genre tagging has not yet been updated may be excluded from this query even if they actively acquire drama. Our drama genre tagging is more complete than horror tagging (which has known gaps around Blumhouse and Neon, addressed in the horror report), but it is not exhaustive.
Signal counts are a measure of trade-press presence, not a count of executed deals. The full method behind every claim in this piece is documented on the methodology page. Next refresh of this report is scheduled for May 2027, with an updated mid-year reading in November 2026.
Sources
This report's aggregate signal counts were pulled directly from ScriptMatch's buyer-intelligence database on May 26, 2026. Drama signal volume per buyer, monthly progression, and 30/90-day activity totals are derived from the underlying buyer_trends table joined to canonical buyer records. Each underlying signal record references a specific named trade-press article from outlets including Variety, The Hollywood Reporter, Deadline, IndieWire, Screen International, TheWrap, and ScreenDaily. Specific source articles for individual buyer claims are available on the buyer profile pages linked above. The aggregate counts in this piece (1,277, 297, 168, etc.) are direct query results, not synthesized estimates.
Get the next edition in your inbox.
Buyer intelligence, festival recaps, and the indie players moving real product. Monday morning.
Who's Buying Documentaries in 2026: The Surge Lane
Documentary acquisition surged in 2026 with signal volume tripling from January to April. The boutique theatrical lane (Kino Lorber, Criterion Collection, Abramorama, Strand Releasing) is active. The international broadcast lane (ITV, JioStar, Nippon TV, RAI) is wider than U.S. writers usually realize. Here is the data.
Who's Buying Horror in 2026: The Most Active Buyers by Signal Volume
A24 led horror buyer activity in 2026 with 268 signals year-to-date. Lionsgate followed at 153, Focus Features at 74. The market accelerated sharply in April with 405 horror signals in a single month. Here is what the data shows about who is buying horror right now.
Q1 2026 Hollywood Buyer Activity: 4,945 Signals from 860 Buyers
ScriptMatch logged 4,945 in-scope buyer signals across Q1 2026 from roughly 860 unique buyers. Netflix led the field at 583 signals; A24 was the only specialty distributor in the top 10. Here is what the data actually shows.